Patent details

Basic Information

Publication number:

EP3280421

PCT Application Number:

US2016026146

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167771682

PCT Publication Number:

WO2016164413

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES POUR THÉRAPIE COMBINÉE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN FÜR EINE KOMBINATIONSTHERAPIE

SPC Number:

Dates

Filing date:

06/04/2016

Grant date:

27/12/2023

EP Publication Date:

14/02/2018

PCT Publication Date:

13/10/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2023

EP B1 Publication Date:

27/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/04/2024

Expiration date:

06/04/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2023

 

 

Name:

Intercept Pharmaceuticals, Inc.

Address:

305 Madison Avenue, Morristown NJ 07960, United States (US)

Inventor

1

Name:

PRUZANSKI, Mark

Address:

United States (US)

2

Name:

ADORINI, Luciano

Address:

Italy (IT)

Priority

Priority Number:

201562144040 P

Priority Date:

07/04/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/575; C07J 43/00; C07J 9/00; A61K 51/00; A61K 31/4985; A61K 31/7048; A61P 1/16; A61P 3/04; A61P 3/10;

Publication

European Patent Bulletin

Issue number:

202352

Publication date:

27/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages